X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-23 | PTGX | Protagonist Therapeutics, Inc | Patel Dinesh V Ph D | Pres, CEO | S - Sale+OE | $84.18 | -48,273 | 574,505 | -8% | -$4,063,743 | |||||
| D | 2026-01-27 | PTGX | Protagonist Therapeutics, Inc | Ali Asif | CFO | S - Sale+OE | $83.13 | -46,203 | 60,320 | -43% | -$3,841,037 | |||||
2026-01-23 | BTGO | Bitgo Holdings, Inc. | Mettler Jody | COO | S - Sale | $16.74 | -25,000 | 25,000 | -50% | -$418,500 | ||||||
| DM | 2026-01-23 | PTGX | Protagonist Therapeutics, Inc | Molina Arturo Md | Chief Medical Officer | S - Sale+OE | $82.30 | -23,151 | 84,115 | -22% | -$1,905,305 | |||||
2026-01-23 | BTGO | Bitgo Holdings, Inc. | Reginelli Edward | CFO | S - Sale | $16.74 | -45,000 | 539,000 | -8% | -$753,300 | ||||||
2026-01-23 | BTGO | Bitgo Holdings, Inc. | Fang Chen | Chief Revenue Officer | S - Sale | $16.74 | -250,000 | 1,233,491 | -17% | -$4,185,000 | ||||||
2026-01-23 | BTGO | Bitgo Holdings, Inc. | Horowitz Jeff Peter | Chief Compliance Officer | S - Sale | $16.74 | -116,007 | 311,118 | -27% | -$1,941,957 | ||||||
| DM | 2026-01-23 | TVTX | Travere Therapeutics, Inc. | Dube Eric M | CEO | S - Sale+OE | $30.09 | -60,000 | 419,173 | -13% | -$1,805,134 | |||||
2026-01-26 | ACN | Accenture Plc | Clifford Katherine Lee | Chief Leadership, HR Officer | S - Sale | $280.79 | -787 | 6,028 | -12% | -$220,985 | ||||||
2026-01-26 | ACN | Accenture Plc | Hogan Catherine Kiernan | COO | S - Sale | $280.93 | -660 | 14,736 | -4% | -$185,412 | ||||||
2026-01-26 | ACN | Accenture Plc | Burgum Melissa A | Chief Accounting Officer | S - Sale | $281.02 | -3,588 | 8,179 | -30% | -$1,008,281 | ||||||
2026-01-27 | ACN | Accenture Plc | Walsh John F | CEO-The Americas | S - Sale | $276.38 | -3,986 | 27,221 | -13% | -$1,101,644 | ||||||
| D | 2026-01-27 | ADBE | Adobe Inc. | Durn Daniel | EVP, CFO | S - Sale+OE | $294.85 | -1,646 | 41,995 | -4% | -$485,323 | |||||
2026-01-26 | NTRS | Northern Trust Corp | Cherecwich Peter | COO | S - Sale | $149.62 | -25,000 | 54,513 | -31% | -$3,740,500 | ||||||
| DM | 2026-01-23 | NAMS | Newamsterdam Pharma Co N.V. | Kooij Louise Frederika | Chief Accounting Officer | S - Sale+OE | $33.29 | -72,572 | 24,353 | -75% | -$2,415,843 | |||||
2026-01-26 | SLB | Slb Limited/Nv | Ralston Dianne B. | GC, Sec | S - Sale | $49.50 | -18,617 | 224,097 | -8% | -$921,542 | ||||||
2026-01-26 | SLB | Slb Limited/Nv | Merad Abdellah | EVP, Core Services, Equipment | S - Sale | $49.70 | -60,000 | 140,602 | -30% | -$2,982,000 | ||||||
2026-01-26 | SLB | Slb Limited/Nv | Guild Howard | Chief Accounting Officer | S - Sale | $49.70 | -13,268 | 22,407 | -37% | -$659,420 | ||||||
| D | 2026-01-26 | SYM | Symbotic Inc. | Kuffner James | CTO | S - Sale+OE | $59.76 | -77,321 | 144,982 | -35% | -$4,621,039 | |||||
| D | 2026-01-26 | SYM | Symbotic Inc. | Freve Maria G | See Remarks | S - Sale+OE | $59.99 | -6,667 | 8,845 | -43% | -$399,957 | |||||
2026-01-26 | SLB | Slb Limited/Nv | Biguet Stephane | EVP, CFO | S - Sale | $49.70 | -61,017 | 155,548 | -28% | -$3,032,545 | ||||||
2026-01-23 | W | Wayfair Inc. | Conine Steven | Co-Founder | S - Sale | $108.87 | -150,000 | 311,930 | -32% | -$16,330,553 | ||||||
2026-01-23 | W | Wayfair Inc. | Shah Niraj | CEO | S - Sale | $108.88 | -150,000 | 311,994 | -32% | -$16,331,184 | ||||||
2026-01-26 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $100.65 | -5,000 | 4,487,950 | 0% | -$503,255 | ||||||
| D | 2026-01-26 | HGTY | Hagerty, Inc. | Ahn Kenneth | Pres, Hagerty Marketplace | S - Sale+OE | $12.41 | -50,000 | 113,593 | -31% | -$620,500 | |||||
2026-01-23 | LTH | Life Time Group Holdings, Inc. | Singh Ritadhwaja Jebens | EVP, Chief Digital Officer | S - Sale | $29.75 | -12,088 | 110,967 | -10% | -$359,618 | ||||||
| D | 2026-01-26 | MIRM | Mirum Pharmaceuticals, Inc. | Bjerkholt Eric | CFO | S - Sale+OE | $96.19 | -1,053 | 43,741 | -2% | -$101,290 | |||||
| D | 2026-01-26 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres, COO | S - Sale+OE | $96.19 | -3,143 | 23,286 | -12% | -$302,331 | |||||
| D | 2026-01-26 | GSBC | Great Southern Bancorp, Inc. | Turner Joseph W | Pres, CEO, 10% | S - Sale+OE | $60.74 | -6,000 | 539,311 | -1% | -$364,427 | |||||
| D | 2026-01-26 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO | S - Sale+OE | $96.19 | -6,831 | 356,902 | -2% | -$657,088 | |||||
2026-01-23 | FLOC | Flowco Holdings Inc. | Roberts Chad | EVP, Production Solutions | S - Sale | $21.47 | -40,884 | 130,014 | -24% | -$877,681 | ||||||
2026-01-26 | TEAM | Atlassian Corp | Cannon-Brookes Michael | CEO, Co-Founder, 10% | S - Sale | $136.93 | -7,665 | 344,925 | -2% | -$1,049,587 | ||||||
2026-01-23 | GS | Goldman Sachs Group Inc | Ruemmler Kathryn H. | GC, GC | S - Sale | $927.51 | -9,589 | 18,533 | -34% | -$8,893,930 | ||||||
2026-01-23 | GS | Goldman Sachs Group Inc | Fredman Sheara J | Chief Accounting Officer | S - Sale | $923.75 | -4,863 | 10,301 | -32% | -$4,492,189 | ||||||
| D | 2026-01-23 | AZO | Autozone Inc | Smith Richard Craig | SVP | S - Sale+OE | $3,700.00 | -5,910 | 2,627 | -69% | -$21,867,000 | |||||
| M | 2026-01-23 | TSHA | Taysha Gene Therapies, Inc. | Nagendran Sukumar | Pres, Head of R, D | S - Sale | $4.72 | -116,050 | 1,317,389 | -8% | -$547,469 | |||||
2026-01-23 | TWST | Twist Bioscience Corp | Finn Patrick John | Pres, COO | S - Sale | $44.91 | -2,390 | 310,493 | -1% | -$107,330 | ||||||
| M | 2026-01-23 | TSHA | Taysha Gene Therapies, Inc. | Nolan Sean P. | CEO | S - Sale | $4.72 | -178,101 | 4,443,802 | -4% | -$840,196 | |||||
| M | 2026-01-23 | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | CFO | S - Sale | $4.72 | -102,817 | 1,443,786 | -7% | -$485,042 | |||||
| D | 2026-01-23 | GS | Goldman Sachs Group Inc | Halio Carey | Global Treasurer | S - Sale+OE | $920.62 | -1,757 | 4,863 | -27% | -$1,617,531 | |||||
| D | 2026-01-22 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $127.68 | -10,498 | 92,366 | -10% | -$1,340,380 | |||||
2026-01-26 | GWRE | Guidewire Software, Inc. | Rosenbaum Michael George | CEO | S - Sale | $160.32 | -1,200 | 234,343 | -1% | -$192,384 | ||||||
| D | 2026-01-23 | GILD | Gilead Sciences, Inc. | O'Day Daniel Patrick | COB, CEO | S - Sale+OE | $135.00 | -115,640 | 566,698 | -17% | -$15,611,400 | |||||
| D | 2026-01-22 | RDDT | Reddit, Inc. | Slowe Christopher Brian | CTO | S - Sale+OE | $212.61 | -14,000 | 187,878 | -7% | -$2,976,561 | |||||
2026-01-22 | MU | Micron Technology Inc | Bhatia Manish H | EVP, Global Operations | S - Sale | $391.04 | -26,623 | 323,486 | -8% | -$10,410,771 | ||||||
2026-01-23 | TEAM | Atlassian Corp | Cannon-Brookes Michael | CEO, Co-Founder, 10% | S - Sale | $130.85 | -7,665 | 352,590 | -2% | -$1,002,961 | ||||||
2026-01-22 | ARES | Ares Management Corp | Sagati Aghili Naseem | GC | S - Sale | $161.84 | -1,849 | 254,671 | -1% | -$299,239 | ||||||
2026-01-22 | KMI | Kinder Morgan, Inc. | Michels David Patrick | VP, CFO | S - Sale | $30.00 | -20,000 | 139,428 | -13% | -$600,000 | ||||||
2026-01-22 | JBL | Jabil Inc | Dastoor Michael | CEO | S - Sale | $246.91 | -15,000 | 262,566 | -5% | -$3,703,604 | ||||||
2026-01-26 | MDGL | Madrigal Pharmaceuticals, Inc. | Huntsman Carole | Chief Commercial Officer | S - Sale | $493.78 | -910 | 9,122 | -9% | -$449,339 | ||||||
| D | 2026-01-22 | CRSP | Crispr Therapeutics AG | Prasad Raju | CFO | S - Sale+OE | $60.19 | -34,972 | 6,767 | -84% | -$2,104,965 | |||||
2026-01-26 | MDGL | Madrigal Pharmaceuticals, Inc. | Sibold William John | Pres, CEO | S - Sale | $492.42 | -1,577 | 148,497 | -1% | -$776,546 | ||||||
| M | 2026-01-22 | ANF | Abercrombie & Fitch Co /De/ | Horowitz Fran | CEO | S - Sale | $96.99 | -203,200 | 505,303 | -29% | -$19,708,347 | |||||
| M | 2026-01-22 | IBKR | Interactive Brokers Group, Inc. | Nemser Earl H | Vice COB | S - Sale | $77.43 | -245,000 | 606,830 | -29% | -$18,969,682 | |||||
| DM | 2026-01-22 | UWMC | Uwm Holdings Corp | Mat Ishbia | Pres, CEO, 10% | S - Sale+OE | $5.82 | -1,898,622 | 3,701,002 | -34% | -$11,056,309 | |||||
| D | 2026-01-26 | EOSE | Eos Energy Enterprises, Inc. | Kroeker Nathan | CCO, Interim CFO | S - Sale+OE | $16.04 | -50,000 | 662,512 | -7% | -$802,000 | |||||
2026-01-22 | RF | Regions Financial Corp | Ritter William D. | SEVP | S - Sale | $28.78 | -36,000 | 18,960 | -66% | -$1,036,062 | ||||||
2026-01-22 | DRI | Darden Restaurants Inc | King Sarah H. | SVP, Chief People Officer | S - Sale | $206.65 | -4,605 | 671 | -87% | -$951,636 | ||||||
2026-01-22 | URBN | Urban Outfitters Inc | Hayne Margaret | Co-Pres, CCO | S - Sale | $71.17 | -9,333 | 23,717,028 | 0% | -$664,222 | ||||||
2026-01-22 | URBN | Urban Outfitters Inc | Hayne Richard A | CEO, COB, 10% | S - Sale | $71.17 | -20,000 | 23,717,028 | 0% | -$1,423,383 | ||||||
2026-01-23 | HWC | Hancock Whitney Corp | Ziluca Christopher S | Chief Credit Officer | S - Sale | $68.57 | -5,227 | 33,301 | -14% | -$358,415 | ||||||
| D | 2026-01-23 | TRV | Travelers Companies, Inc. | Klenk Jeffrey P. | EVP, Pres, Bond, Spec. Ins. | S - Sale+OE | $279.78 | -16,712 | 6,075 | -73% | -$4,675,593 | |||||
2026-01-23 | ACN | Accenture Plc | Unruch Joel | GC, Corp Secretary | S - Sale | $281.70 | -1,026 | 27,181 | -4% | -$289,024 | ||||||
| M | 2026-01-22 | PATH | Uipath, Inc. | Dines Daniel | CEO, COB, 10% | S - Sale | $15.09 | -135,000 | 37,508,882 | 0% | -$2,037,227 | |||||
2026-01-22 | CRDO | Credo Technology Group Holding Ltd | Cheng Chi Fung | CTO | S - Sale | $136.33 | -30,000 | 6,438,590 | 0% | -$4,089,941 | ||||||
2026-01-23 | RPRX | Royalty Pharma Plc | Urist Marshall | EVP, Research, Investments | S - Sale | $40.26 | -20,000 | 46,418 | -30% | -$805,110 | ||||||
| D | 2026-01-22 | MAZE | Maze Therapeutics, Inc. | Bachrodt Amy | SVP, Finance | S - Sale+OE | $45.52 | -5,000 | 12,965 | -28% | -$227,612 | |||||
2026-01-22 | SMTC | Semtech Corp | Silberstein Asaf | EVP, COO | S - Sale | $83.00 | -5,000 | 88,496 | -5% | -$415,000 | ||||||
2026-01-22 | BEAM | Beam Therapeutics Inc. | Cavanagh Bethany J | SVP, Finance, Treasurer | S - Sale | $35.00 | -6,198 | 34,813 | -15% | -$216,933 | ||||||
2026-01-22 | MCHP | Microchip Technology Inc | Sanghi Steve | Pres, CEO, Chair of Bd | S - Sale | $79.20 | -18,509 | 10,021,133 | 0% | -$1,465,883 | ||||||
| D | 2026-01-23 | PG | Procter & Gamble Co | Pritchard Marc S. | Chief Brand Officer | S - Sale+OE | $151.15 | -95,903 | 231,811 | -29% | -$14,495,690 | |||||
2026-01-22 | PFG | Principal Financial Group Inc | Strable-Soethout Deanna D | Pres, CEO | S - Sale | $92.56 | -8,025 | 54,227 | -13% | -$742,794 | ||||||
| D | 2026-01-23 | HAL | Halliburton Co | Miller Jeffrey Allen | Dir, Pres, CEO | S - Sale+OE | $34.96 | -171,200 | 1,101,243 | -13% | -$5,985,152 | |||||
| D | 2026-01-23 | HAL | Halliburton Co | Beckwith Van H. | EVP, Secretary, CLO | S - Sale+OE | $34.96 | -54,348 | 344,535 | -14% | -$1,900,006 | |||||
| D | 2026-01-22 | SCHW | Schwab Charles Corp | Beatty Jonathan S | MD, Head of Advisor Services | S - Sale+OE | $105.00 | -2,000 | 55,263 | -3% | -$210,003 | |||||
| D | 2026-01-21 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $124.65 | -4,502 | 92,366 | -5% | -$561,174 | |||||
2026-01-23 | DC | Dakota Gold Corp. | Quartermain Robert | CEO | S - Sale | $6.88 | -250,000 | 7,493,244 | -3% | -$1,720,875 | ||||||
2026-01-21 | GOOGL | Alphabet Inc. | Pichai Sundar | CEO | S - Sale | $327.30 | -32,500 | 2,439,432 | -1% | -$10,637,368 | ||||||
2026-01-23 | CENX | Century Aluminum Co | Gary Jesse E | Pres, CEO | S - Sale | $48.19 | -150,000 | 569,807 | -21% | -$7,228,500 | ||||||
| D | 2026-01-21 | DC | Dakota Gold Corp. | Campbell Shawn | CFO | S - Sale+OE | $6.30 | -55,000 | 500,851 | -10% | -$346,291 | |||||
| D | 2026-01-22 | AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | CFO | S - Sale+OE | $187.92 | -12,000 | 43,076 | -22% | -$2,255,040 | |||||
| D | 2026-01-21 | AXSM | Axsome Therapeutics, Inc. | Maizel Ari | Chief Commercial Officer | S - Sale+OE | $184.44 | -7,500 | 0 | -100% | -$1,383,300 | |||||
| D | 2026-01-21 | BLK | Blackrock, Inc. | Kushel J. Richard | Senior MD | S - Sale+OE | $1,125.00 | -20,000 | 141,072 | -12% | -$22,500,000 | |||||
2026-01-22 | TEAM | Atlassian Corp | Cannon-Brookes Michael | CEO, Co-Founder, 10% | S - Sale | $126.11 | -7,665 | 360,255 | -2% | -$966,640 | ||||||
| M | 2026-01-21 | CDNA | Caredx, Inc. | Hanna John Walter Jr | Pres, CEO | S - Sale | $21.16 | -19,480 | 597,405 | -3% | -$412,223 | |||||
2026-01-22 | IONS | Ionis Pharmaceuticals Inc | Devers Shannon L. | EVP, Chief HR Ofc | S - Sale | $81.34 | -3,977 | 22,541 | -15% | -$323,490 | ||||||
2026-01-22 | WMT | Walmart Inc. | McMillon C Douglas | Pres, CEO | S - Sale | $119.17 | -19,416 | 5,334,561 | 0% | -$2,313,875 | ||||||
| DM | 2026-01-21 | AMPX | Amprius Technologies, Inc. | Stefan Constantin Ionel | CTO | S - Sale+OE | $12.03 | -567,707 | 748,696 | -43% | -$6,830,523 | |||||
2026-01-21 | RNA | Avidity Biosciences, Inc. | Hughes Steven George | Chief Medical Officer | S - Sale | $72.45 | -4,895 | 31,599 | -13% | -$354,643 | ||||||
2026-01-21 | RNA | Avidity Biosciences, Inc. | Boyce Sarah | Pres, CEO | S - Sale | $72.45 | -14,387 | 269,007 | -5% | -$1,042,338 | ||||||
2026-01-21 | RNA | Avidity Biosciences, Inc. | Flanagan W. Michael | Chief Scientific Officer | S - Sale | $72.45 | -6,534 | 85,093 | -7% | -$473,388 | ||||||
2026-01-21 | RNA | Avidity Biosciences, Inc. | Maclean Michael F | CFO | S - Sale | $72.45 | -4,542 | 59,290 | -7% | -$329,068 | ||||||
2026-01-21 | RNA | Avidity Biosciences, Inc. | McCarthy Teresa | CHRO | S - Sale | $72.45 | -2,929 | 113,938 | -3% | -$212,206 | ||||||
| D | 2026-01-22 | MIRM | Mirum Pharmaceuticals, Inc. | Quan Joanne | CHIEF MEDICAL OFFICER | S - Sale+OE | $93.33 | -1,822 | 12,817 | -12% | -$170,039 | |||||
| D | 2026-01-22 | MIRM | Mirum Pharmaceuticals, Inc. | Bjerkholt Eric | CFO | S - Sale+OE | $93.33 | -1,421 | 42,127 | -3% | -$132,615 | |||||
| D | 2026-01-22 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres, COO | S - Sale+OE | $93.33 | -2,382 | 20,679 | -10% | -$222,301 | |||||
| D | 2026-01-22 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CEO | S - Sale+OE | $93.33 | -7,098 | 351,233 | -2% | -$662,422 | |||||
| D | 2026-01-22 | CMA | Comerica Inc | Weber James Harry | EVP | S - Sale+OE | $98.04 | -8,798 | 20,543 | -30% | -$862,556 | |||||
2026-01-22 | CMA | Comerica Inc | Carr James McGregor | Exec Vice Pres | S - Sale | $98.06 | -10,000 | 23,959 | -29% | -$980,600 | ||||||
2026-01-21 | BOX | Box Inc | Nottebohm Olivia | COO | S - Sale | $26.04 | -4,612 | 469,831 | -1% | -$120,101 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |